Skip to main content

Table 1 Baseline Characteristics of 21 Patients (21 Eyes) with Macular Edema after BRVO

From: Correlation between short- and long-term effects of intravitreal ranibizumab therapy on macular edema after branch retinal vein occlusion: a prospective observational study

Age (years, mean ± SD)

71.0 ± 10.3

Gender (male/female)

6/15

Symptom duration (months, mean ± SD)

9.4 ± 11.2

History of photocoagulation (eyes)

2 (10%)

BCVA (logMAR, mean ± SD)

(Snellen equivalent)

0.65 ± 0.28

20/89

Baseline FT (μm, mean ± SD)

482 ± 85

Phakic eye (eyes)

19 (90%)

Systemic hypertension (patients)

11 (52%)

Diabetes mellitus (patients)

0 (0%)

  1. BRVO branch retinal vein occlusion, logMAR logarithm of the minimum angle of resolution, SD standard deviation, BCVA best-corrected visual acuity, FT foveal thickness